Moderna (MRNA) Non-Current Deferred Revenue (2017 - 2026)
Moderna (MRNA) posted Non-Current Deffered Revenue of $147 million for Q2 2026, up 126.2% from $65 million a year earlier but down 4.5% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Non-Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna's Non-Current Deffered Revenue came in at $153 million, up 163.8% from FY2024.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- In prior years, Moderna's Non-Current Deffered Revenue was $58 million in FY2024 (-30.1%), $83 million in FY2023 (-87.7%), $673 million in FY2022 (+9.4%) and $615 million in FY2021 (+247.5%).
- Quarterly Non-Current Deffered Revenue has run from a low of $58 million in Q1 2024 to a high of $692 million in Q2 2023 over five years.
- On a year-over-year basis, Non-Current Deffered Revenue has increased in each of the last four quarters, with growth averaging 52.0% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q4 2021, with growth of 247.5%; the weakest was Q1 2024, with a decline of 91.4%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $154 million (Q1 2026), $153 million (Q4 2025) and $157 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 147.00 Mn |
| Mar 31, 2026 | 154.00 Mn |
| Dec 31, 2025 | 153.00 Mn |
| Sep 30, 2025 | 157.00 Mn |
| Jun 30, 2025 | 65.00 Mn |
| Mar 31, 2025 | 58.00 Mn |
| Dec 31, 2024 | 58.00 Mn |
| Sep 30, 2024 | 95.00 Mn |
| Jun 30, 2024 | 95.00 Mn |
| Mar 31, 2024 | 58.00 Mn |
| Dec 31, 2023 | 83.00 Mn |
| Sep 30, 2023 | 166.00 Mn |
| Jun 30, 2023 | 692.00 Mn |
| Mar 31, 2023 | 673.00 Mn |
| Dec 31, 2022 | 673.00 Mn |
| Sep 30, 2022 | 175.00 Mn |
| Jun 30, 2022 | 405.00 Mn |
| Mar 31, 2022 | 464.00 Mn |
| Dec 31, 2021 | 615.00 Mn |
| Sep 30, 2021 | 498.00 Mn |
API Access
Moderna Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();